Generix Lifesciences Private Limited, a active private limited company, was established on 13 June 2007 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24110DL2007PTC164689. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.00 Cr.
It upholds a compliant status. Employing 4 professional, Its leadership includes Rekha Jha (Director), Sandeep Jha (Director). Past directors included Vinod Nair, Rekha Jha, Ramesh Rajan. It holds ₹8.90 Cr open charges and ₹13.48 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ground Floor 207 Shahpur Jat, New Delhi, Delhi, 110049.
U24110DL2007PTC164689
164689
13 June 2007
₹5.00 Cr
₹4.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Generix Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rekha Jha | Director | 26 Nov 2020 | Current |
| Sandeep Jha | Director | 13 Jun 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 09 Jun 2015 | Past |
| Pramod Abcsdd | Director | 05 Mar 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Generix Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.01% decrease. The company also saw a substantial improvement in profitability, with a 44.52% increase in profit. The company's net worth observed a substantial decline by a decrease of 36.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Generix Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹89,000,000.00
₹134,779,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Aug 2017 | Others | ₹8.90 Cr | Satisfied |
| 27 Jun 2016 | Others | ₹1.05 Cr | Satisfied |
| 29 Jan 2015 | Edelweiss Retail Finance Limited | ₹1.87 Cr | Satisfied |
| 29 Nov 2014 | Edelweiss Retail Finance Limited | ₹1.13 Cr | Satisfied |
| 28 Sep 2010 | Kotak Mahindra Bank Limited | ₹5.30 M | Satisfied |
Explore comprehensive loan charge details -
Generix Lifesciences has a workforce of 4 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Generix Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Generix Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 25 Aug 2017 via Charge ID 100122192 with Others was fully satisfied on 03 Jan 2025. was completed.
The activity Generix Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Generix Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Others of Rs. 8.90 Cr registered on 25 Aug 2017 with Charge ID 100122192 was modified on 11 Feb 2021. was completed.
Rekha Jha was appointed as a Director was appointed as a Director on 26 Nov 2020 & has been associated with this company since 5 years 2 days . was recorded as a recent event.
A charge registered on 27 Jun 2016 via Charge ID 100043629 with Others was fully satisfied on 06 Nov 2017. was recorded as a recent event.
The CIN of Generix Lifesciences Private Limited is U24110DL2007PTC164689.
Generix Lifesciences Private Limited is headquartered at Ground Floor 207 Shahpur Jat, New Delhi, Delhi, 110049.
Generix Lifesciences Private Limited was incorporated on 13 June 2007.
The current directors of Generix Lifesciences Private Limited are
The primary industry of Generix Lifesciences Private Limited is Trade.
Generix Lifesciences Private Limited is unlisted.
The authorized capital of Generix Lifesciences Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.00 Cr.
The compliance status of Generix Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX